Archive - November 2018
First children set to receive Novartis’ Kymriah
DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration
Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration
Glenmark Pharmaceuticals Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018
Join the medical & scientific community at the MSEA awards 2018
US grants AZ’ Fasenra orphan drug status for rare autoimmune disease
Poteligeo approved in Europe for Mycosis Fungoides, Sézary Syndrome
Loxo, Bayer get FDA okay for biomarker-driven cancer drug